This study is the first to reveal that geniposide exerts its antidepressant effects by upregulating lncRNA Six3os1, suppressing MAPK/NLRP3 pathway activation and inflammasome formation in a depression mouse model. The gene discussed is NLRP3; the disease is major depressive disorder.